A novel fully human anti-NCL immunoRNase for triple-negative breast cancer therapy
Chiara D’Avino(Ceinge Biotecnologie Avanzate (Italy)), Claudia De Lorenzo(Istituto Nazionale di Fisica Nucleare, Sezione di Napoli)
Cited by 25
Related Papers
Two novel human anti-ErbB2 immunoagents are active on trastuzumab-resistant tumours
|British Journal of Cancer|2010|39
Novel human neutralizing mAbs specific for Spike-RBD of SARS-CoV-2
|Scientific Reports|2021|21
Novel Bi-Specific Immuno-Modulatory Tribodies Potentiate T Cell Activation and Increase Anti-Tumor Efficacy
|International Journal of Molecular Sciences|2022|10